Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hallgeir Rui

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
JCO Precision Oncology|January 18, 2023
High PD-L2 Predicts Early Recurrence of ER-Positive Breast CancerInna Chervoneva, Amy R Peck, Yunguang Sun, et al.
Molecular Cancer Therapeutics|May 31, 2015
Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid LeukemiaZhiyong Liao, Lei Gu, Jenny Vergalli, et al.
Journal of the American Heart Association|February 15, 2023
Collagen-Specific HSP47<sup>+</sup> Myofibroblasts and CD163<sup>+</sup> Macrophages Identify Profibrotic Phenotypes in Deceased Hearts With SARS-CoV-2 InfectionsAndrii Puzyrenko, Elizabeth R Jacobs, Nathan Padilla, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapiesQuoc Thang Bui, Raghavendra Basavaraja, Mayura R Dhamdhere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancerClay E S Comstock, Michael A Augello, Ruth Pe Benito, et al.
Cancer Cell|January 16, 2019
An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular VesiclesAngelica Ortiz, Jun Gui, Farima Zahedi, et al.
Oncogene|April 24, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
Research Square|January 30, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
JCO Precision Oncology|January 18, 2023
High PD-L2 Predicts Early Recurrence of ER-Positive Breast CancerInna Chervoneva, Amy R Peck, Yunguang Sun, et al.
Molecular Cancer Therapeutics|May 31, 2015
Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid LeukemiaZhiyong Liao, Lei Gu, Jenny Vergalli, et al.
Journal of the American Heart Association|February 15, 2023
Collagen-Specific HSP47<sup>+</sup> Myofibroblasts and CD163<sup>+</sup> Macrophages Identify Profibrotic Phenotypes in Deceased Hearts With SARS-CoV-2 InfectionsAndrii Puzyrenko, Elizabeth R Jacobs, Nathan Padilla, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapiesQuoc Thang Bui, Raghavendra Basavaraja, Mayura R Dhamdhere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancerClay E S Comstock, Michael A Augello, Ruth Pe Benito, et al.
Cancer Cell|January 16, 2019
An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular VesiclesAngelica Ortiz, Jun Gui, Farima Zahedi, et al.
Oncogene|April 24, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
Research Square|January 30, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
Pageof 14